Using linked data to calculate summary measures of population health: Health-adjusted life expectancy of people with diabetes mellitus

Population Health Metrics

Volumn 2, Issue , 2004, Pages

  Manuel, Douglas G ^a,b   Schultz, Susan E ^a  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; DISABILITY; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH STATISTICS; HEALTH STATUS; HEALTH SURVEY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; PHYSICIAN; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; SELF REPORT; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 4344686783     PISSN: 14787954     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-7954-2-4     Document Type: Article

References (51)

1. Summary measures of population health: concepts, ethics, measurement and applications (Edited by: Murray CJL, Salomon J, Mathers CD and Lopez AD). Geneva, World Health Organization 2002.
2. Determining Health Expectancies (Edited by: Robine J-M, Jagger C, Mathers CD, Crimmins EM and Suzman RM). Chichester, UK, John Wiley & Sons Ltd. 2003.
3. Manuel DG, Goel V, Williams JI, Corey P: Health-adjusted Life Expectancy at the Local Level in Ontario. Chronic Dis Can 2000, 21:73-80.
4. Wolfson MC: Health-adjusted life expectancy. Health Rep 1996, 8:41-46.
5. Hyder AA, Rotllant G, Morrow RH: Measuring the burden of disease: healthy life-years. Am J Public Health 1998, 88:196-202.
6. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (Edited by: Murray CJ and Lopez AD). Washington, Harvard School of Public Health on behalf of the World Health Organization and the World Bank 1996.
7. Heliovaara M, Aromaa A, Klaukka T, Knekt P, Joukamaa M, Impivaara O: Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol 1993, 46:181-191.
8. Beckett M, Weinstein M, Goldman N, Yu-Hsuan L: Do health interview surveys yield reliable data on chronic illness among older respondents? Am J Epidemiol 2000, 151:315-23.
9. Gross R, Bentur N, Elhayany A, Sherf M, Epstein L: The validity of self-reports on chronic disease: Characteristics of underreporters and implications for the planning of services. Public Health Rev 1996, 24:167-182.
10. Jabine TB: Reporting chronic conditions in the National Health Interview Survey. A review of findings from evaluation studies and methodological test. Vital Health Stat 2 1987, 1-45.
11. Moesgaard-Iburg K, Salomon J, Tandon A: Cross population comparability of self-reported and physician-assessed mobility levels: Evidence from the Third National Health and Nutrition Exam Survey. Geneva, World Health Organization 2001., Evidence and Information for Policy Discussion Paper No. 14:
12. Canada Statistics: 1996-97 NPHS Public Use Microdata Documentation. Ottawa 1999.
13. Diabetes Health Status and Risk Factors Diabetes in Ontario: An ICES Practice Atlas (Edited by: Hux JE, Booth G, Slaughter PM and Laupacis A). Toronto, Institute for Clinical Evaluative Sciences 2003, 4.77-4.94.
14. Swain L, Catlin G, Beaudet MP: The National Population Health Survey - its longitudinal nature. Health Rep 1999, 10:69-82.
15. Rao JNK, Wu CFJ, Yue K: Some recent work on resampling methods for complex surveys. Survey Methodology Ottawa, Statistics Canada 1992, 18:209-217.
16. Rust KF, Rao JN: Variance estimation for complex surveys using replication techniques. Stat Methods Med Res 1996, 5:283-310.
17. Yeo D, Mantel H, Liu TP: Bootstrap variance estimation for the National Population Health Survey. Baltimore, American Statistical Association 1999, 778-783.
18. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002, 25:512-516.
19. Blanchard JF, Ludwig S, Wajda A, Dean H, Anderson K, Kendall O, Depew N: Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care 1996, 19:807-11.
20. Baan CA, Nusselder WJ, Barendregt JJ, Ruwaard D, Bonneux L, Feskens EJ: The burden of mortality of diabetes mellitus in The Netherlands. Epidemiology 1999, 10:184-187.
21. Jagger C, Goyder E, Clarke M, Brouard N, Arthur A: Active life expectancy in people with and without diabetes. J Public Health Med 2003, 25:42-46.
22. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998, 21:1138-1145.
23. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884-1890.
24. Feeny DH, Torrance GW, Furlong WJ: Health Utilities Index - Chapter 26. Quality of Life and Pharmacoeconomics in Clinical Trials Second Edition (Edited by: Spilder B). Philadelphia, Lippincott-Raven 1996.
25. Feeny D, Furlong W, Boyle M, Torrance GW: Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 1995, 7:490-502.
26. Coons SJ, Rao S, Keininger DL, Hays RD: A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000, 17:13-35.
27. Hawthorne G, Richardson J, Day NA: A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 2001, 33:358-70.
28. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M: Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 2002, 40:113-128.
29. Organization World Health: International Classification of Function, Disability and Health: ICF Geneva, World Health Organization 2001, -299.
30. Torrance GW, Furlong W, Feeny D, Boyle M: Multi-attribute Preference Functions - Health Utilities Index. Pharmacoeconomics 1995, 7:503-520.
31. Health Utilities Group / Health Utilities Index and Quality-of-Life http://www fhs mcmaster ca/hug/ 2004.
32. Furlong W, Feeny D, Torrance G, Barr R: The Health Utilities Index (HUI3) System for Assessing Health-Related Quality of Life in Clinical Studies. 1-56. 2001. Hamilton, Ontario, Centre for Health Economics and Policey Analysis, McMaster University. Health Economics and Policy Analysis Research Working Paper
33. Chiang CL: The Life Table and Its Applications Malabar, Florida, Robert E. Krieger Publ. Co. 1984, 1-316.
34. Hsieh JJ: A general theory of life table construction and a precise abridged life table method. Biom J 1991, 33:143-162.
35. Newman SC: Formulae for cause-deleted life tables. Stat Med 1987, 6:527-8.
36. Sullivan DF: A single index of mortality and morbidity. HSMHA Health Reports 1971, 86:347-54.
37. Mathers C, Vos T, Stevenson C: The burden of disease and injury in Australia. Canaberra, Australian Institute of Health and Welfare 1999., PHE17:
38. MP Fay, ER Feuer: Confidence intervals for directly standardized rates: A method based on the gamma distribution. Stat Med 1997, 16:791-801.
39. Manuel DG, Schultz SE, Kopec JA: Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities Index. J Epidemiol Community Health 2002, 56:843-850.
40. Hux JE, Jacka R, Fuug K, Rothwell D: Diabetes and Peripheral Vascular Diseases. An ICES Practical Atlas. Institute for Clinical Evaluative Sciences(Edited by: Hux JE, Booth G, Slaughter PM, Laupacis A. Toronto). 2003, 6:-.
41. Manuel DG, Schultz SE: Adding Life to Years and Years to Life: Life and Health Expectancy in Ontario. An ICES Atlas Report Toronto, Institute for Clinical Evaluative Sciences 2001.
42. Nusselder WJ, van der Velden K, van Sonsbeek JL, Lenior ME, van den Bos GA: The elimination of selected chronic diseases in a population: the compression and expansion of morbidity. Am J Public Health 1996, 86:187-94.
43. Alter DA, Naylor CD, Austin P, Tu JV: Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 1999, 341:1359-67.
44. Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor CD: Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 2000, 356:639-644.
45. Heller RF, Dobson AJ: Disease impact number and population impact number: population perspectives to measures of risk and benefit. BMJ 2000, 321:950-953.
46. Berthelot J-M, Roberge R, Wolfson MC: The calculation of health-adjusted life expectancy for a Canadian province using a multi-attribute utility function: a first attempt. Calculation of health expectancies: harmonization, consensus achieved and future perspectives (Edited by: Robine J-M, Mathers CD, Bone I and Romieu I). London, John Libbey and Company Ltd. 1993.
47. Barendregt JJ: Incidence- and Prevalence-based SMPH: Making the Twain Meet. Summary measures of population health: concepts, ethics, measurement and applications (Edited by: MurrayCJL, SalomonJ, MathersCD and LopezAD). Geneva, World Health Organization 2002, 221-222.
48. Murray CJ, Salomon JA, Mathers C: A critical examination of summary measures of population health. Bull World Health Organ 2000, 78:981-994.
49. Chapter 11: Mortality in Non-Insulin-Dependant Diabetes Diabetes in America 2nd Edition Edition (Edited by: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE and Bennet PH). Washington, DC, Government Printing Office; NIH Publication 95-1468 1995, 11:233-257.
50. Sadana R, Mathers CD, Lopez AD, Murray CJL, Iburg K: Comparative Analyses of More Than 50 Household Surveys on Health Status. Geneva, World Health Organization 2000, Evidence and Information for Policy Discussion Paper No. 15:1-77.
51. Stouthard MEA, Essink-Bot M-L, Bonsel GJ, Barendregt JJ, Kramer PGN, van de Water HPA, van der Maas PJ, Gunning-Schepers LJ: Disability Weights for Diseases in The Netherlands. Rotterdam, Department of Public Health, Erasmus University Rotterdam 1997.